Development of TRAIL-R2 synthetic trimer agonists for cancer therapy

被引：0
|
作者：
Angell, Y. M.
Frederick, B. T.
Green, J.
Schatz, P. J.
Whitehorn, E. A.
Wright, K. L.
Holmes, C. H.
机构：
[1] Affymax Inc, Dept Chem, Palo Alto, CA 94304 USA
[2] Affymax Inc, Dept Biol, Palo Alto, CA 94304 USA
来源：
BIOPOLYMERS | 2007年 / 88卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：532 / 532
页数：1
相关论文
共 50 条
  • [21] Upregulation of TRAIL-R2 is not involved in HDACi mediated sensitization to TRAIL-induced apoptosis
    Inoue, S.
    Twiddy, D.
    Dyer, M. J. S.
    Cohen, G. M.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (12): : 2160 - 2162
  • [22] Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2
    Mori, E
    Thomas, M
    Motoki, K
    Nakazawa, K
    Tahara, T
    Tomizuka, K
    Ishida, I
    Kataoka, S
    CELL DEATH AND DIFFERENTIATION, 2004, 11 (02): : 203 - 207
  • [23] Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors
    Letícia da Conceição Braga
    Luciana Maria Silva
    Josiane Barbosa Piedade
    Paulo Traiman
    Agnaldo Lopes da Silva Filho
    Archives of Gynecology and Obstetrics, 2014, 289 : 1061 - 1069
  • [24] TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor
    Nahacka, Zuzana
    Svadlenka, Jan
    Peterka, Martin
    Ksandrova, Marie
    Benesova, Simona
    Neuzil, Jiri
    Andera, Ladislav
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2018, 1865 (03): : 522 - 531
  • [25] Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors
    Braga, Leticia da Conceicao
    Silva, Luciana Maria
    Piedade, Josiane Barbosa
    Traiman, Paulo
    da Silva Filho, Agnaldo Lopes
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 289 (05) : 1061 - 1069
  • [26] Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2
    E Mori
    M Thomas
    K Motoki
    K Nakazawa
    T Tahara
    K Tomizuka
    I Ishida
    S Kataoka
    Cell Death & Differentiation, 2004, 11 : 203 - 207
  • [27] The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection
    Miarka, Lauritz
    Hauser, Charlotte
    Helm, Ole
    Holdhof, Doerthe
    Beckinger, Silje
    Egberts, Jan-Hendrik
    Gundlach, Jan-Paul
    Lenk, Lennart
    Rahn, Sascha
    Mikulits, Wolfgang
    Trauzold, Anna
    Sebens, Susanne
    CANCERS, 2019, 11 (06):
  • [28] The effect of opposing roles of NF-kB on TRAIL-R2 expression in TRAIL cytotoxicity in neuroblastoma cells
    Jung, Hye Lim
    Lee, Myoung Woo
    Kim, Hye Ryung
    Kim, Dae Sung
    Kim, Hye Jin
    Lee, Soo Hyun
    Chueh, Hee Won
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    CANCER RESEARCH, 2011, 71
  • [29] TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2
    Taro Tamada
    Daisuke Shinmi
    Masahiro Ikeda
    Yasushi Yonezawa
    Shiro Kataoka
    Ryota Kuroki
    Eiji Mori
    Kazuhiro Motoki
    Scientific Reports, 5
  • [30] Trail-R2: A death receptor turns malignant upon nuclear localization
    Kalthoff, Holger
    Haselmann, Verena
    Kurz, Alexandra
    Bertsch, Uwe
    Huebner, Sebastian
    Fritsche, Hendrik
    Hauser, Charlotte
    Schem, Christian
    Tower, Rob
    Heilmann, Thorsten
    Tiwari, Sanjay
    Glueer, Claus C.
    Trauzold, Anna
    CANCER RESEARCH, 2014, 74 (19)
12345